Close Menu

NEW YORK (GenomeWeb) – Sophia Genetics said today that it has received CE-IVD designation for its Solid Tumor Solution (STS) molecular diagnostic application.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.